Meningococcal Vaccines Market to Reach US$ 4.4 Billion Globally by 2022

New York, May 04: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits from individual to individual through respiratory beads. It can bring about serious cerebrum harm and is deadly in half of the cases if not treated at the right time; and can leave diligent neurological deformities in upwards of 10-15% of survivors.

How Big is the Global Meningococcal Vaccines Market?

The Global Meningococcal Vaccines Market is expected to exceed more than US$ 4.4 billion by 2022 and will grow at a CAGR of more than 12% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/meningococcal-vaccines-market-report

The major driving factors of Global Meningococcal Vaccines Market are as follows:

• Reshaping global health and development by developing countries.
• NGO’s (Non-Profit Organizations) playing an important role in Educating and making awareness through various activities conducted.
• Travel vaccines for meningococcal disease.
• Convenient public-private partnerships to support development of vaccines at low cost.

The restraining factors of Global Meningococcal Vaccines Market are as follows:

• Divergentage groups and prescribed regimen for routine immunization, and unstable and dynamic epidemiology of meningococcal disease.
• To Support the cold chains to deliver vaccines this leads to high cost of vaccination.

The Global Meningococcal Vaccines Market is segmented on the lines of its product, service, software, type and regional. Based on product segmentation it covers Polysaccharide Vaccines, by Brand Menomune, Mencevax, NmVac4, Others include Quadri Meningo, Bi Meningo, Fuether Conjugate Vaccines, by Brand includes Menactra, Menveo, NeisVac-C, Nimenrix, Meningitec, Menjugate, MenAfriVac, NmVac4-DT. Combination Vaccines Brands are as under, MenHibrix, Menitorix. In Men B Vaccines by brand covers Bexsero, Trumenba.

The Global Meningococcal Vaccines Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Global Meningococcal Vaccines Market and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for Global Meningococcal Vaccines Market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets on Global Meningococcal Vaccines Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, JN-International Medical Corporation, Novartis International AG, GlaxoSmithKline plc, Sanofi S.A. Inc., Serum Institute of India Ltd., Nuron Biotech. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global Meningococcal Vaccines Market has been segmented as below:

By Type Analysis

• Polysaccharide Vaccines, by Brand
Menomune
Mencevax
NmVac4
Others
Quadri Meningo
Bi Meningo

• Conjugate Vaccines, by Brand
Menactra
Menveo
NeisVac-C
Nimenrix
Meningitec
Menjugate
MenAfriVac
NmVac4-DT

• Combination Vaccines, by Brand
MenHibrix
Menitorix

• Men B Vaccines, by Brand
Bexsero
Trumenba

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all global Global Meningococcal Vaccines Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Meningococcal Vaccines Market data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.